Brownsville, TX

June 5, 2014—Many ThyCa members have reported difficulty getting Unithroid® pills for their thyroid hormone replacement. The most frequent difficulty has been with the 125 mcg dosage.

We asked Lannett Pharmaceutical whether it is having production issues with Unithroid.

Lannett replied that some items are on backorder, that this is a short term circumstance, and that there is no production issue with the product. Unithroid® will be available for most strengths within the next few weeks.

If anyone has difficulty getting their Unithroid® prescription filled, Lannett suggests that they use Lannett’s/Jerome Stevens generic Levothyroxine Sodium, and adds that it is exactly the same as Unithroid® and the generic is readily available in all strengths at local Walgreens or Kroger.

Douglas Van Nostrand, M.D., Nuclear Medicine Physician, is Director of Nuclear Medicine of the Division of Medicine at Washington Hospital Center in Washington, DC. He is also Professor of Medicine at Georgetown University Hospital and Director of the Washington Hospital Center’s nuclear medicine residency program. Prior to joining the Hospital Center, Dr. Van Nostrand was director of nuclear medicine at Good Samaritan Hospital in Baltimore, Maryland, after serving in the United States Army as director of nuclear medicine at Walter Reed Army Medical Center and in the US Air Force as director of nuclear medicine at Malcolm Grow Medical Center in Washington, D.C. Dr. Van Nostrand completed his postgraduate training in internal medicine at Wilford Hall Medical Center in San Antonio, Texas, and his nuclear medicine training at the National Naval Medical Center in Bethesda, Maryland. He has an M.D. degree from Emory University School of Medicine and a B.S. from Duke University. He has held numerous leadership positions, has received numerous awards, and has authored or coauthored more than 100 abstracts, articles, and chapters. He also has edited and co-edited seven medical books for professionals and patients including the patients’ reference Thyroid Cancer: A Guide for Patients, and the medical textbook co-authored with Dr. Leonard Wartofsky, Thyroid Cancer: A Comprehensive Guide to Clinical Management.

Extensive Thyroid Cancer Resources & Support Available on Our Website

June 30, 2013 — ThyCa’s web site, with more than 750 pages of quality information about thyroid cancer, support services, events, and free downloadable publications in 5 languages, has been updated and redesigned. The site provides fast and easy access to up-to-date physician-reviewed information, free support services available worldwide, and additional resources on the cancer that’s the fastest increasing cancer in the U.S.

Specific information on all types of thyroid cancer, testing, treatment, research, living with the disease, Webinars with experts, and downloadable materials in English, Spanish, Japanese, French, and Chinese, are all available on the site. Added features include the Calendar of Events, plus details about the annual International Thyroid Cancer Survivors’ Conference, Thyroid Cancer Awareness Month, ThyCa’s research fundraising and thyroid cancer research grants, and more.